ARTICLE | Financial News
CRISPR stocks up on Gilead's gene editing interest
February 7, 2018 11:47 PM UTC
CRISPR-based stocks made gains Wednesday after Gilead Sciences Inc. (NASDAQ:GILD) said in its 4Q17 earnings late Tuesday that it was pursuing deals in gene editing (see BioCentury Extra, Feb. 6)...